Related references
Note: Only part of the references are listed.The DNA methylation landscape of hematological malignancies: an update
Pedro Blecua et al.
MOLECULAR ONCOLOGY (2020)
Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?
Theoharis C. Theoharides et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
MicroRNA Involvement in Allergic and Non-Allergic Mast Cell Activation
Irit Shefler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches
Peter Valent et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis
G. Martinelli et al.
LEUKEMIA (2018)
Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo
Mira Jeong et al.
CELL REPORTS (2018)
Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
Johanna S. Ungerstedt
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses
Dylan Krajewski et al.
FRONTIERS IN IMMUNOLOGY (2018)
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent et al.
BLOOD (2017)
Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis
Katarina Lyberg et al.
ONCOTARGET (2017)
Tryptase-catalyzed core histone truncation: A novel epigenetic regulatory mechanism in mast cells
Fabio R. Melo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Dnmt3a restrains mast cell inflammatory responses
Cristina Leoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent et al.
CANCER RESEARCH (2017)
Concurrent activating KIT mutations in systemic mastocytosis
Terra Lasho et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival
Animesh Pardanani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management
Animesh Pardanani
AMERICAN JOURNAL OF HEMATOLOGY (2016)
lncRNAs and microRNAs with a role in cancer development
Julia Liz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
TET2 Regulates Mast Cell Differentiation and Proliferation through Catalytic and Non-catalytic Activities
Sara Montagner et al.
CELL REPORTS (2016)
Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis
Cristina Leoni et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia
G. Wedeh et al.
LEUKEMIA (2015)
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis
M. Arock et al.
LEUKEMIA (2015)
Molecular basis of mast cell disease
Erinn Soucie et al.
MOLECULAR IMMUNOLOGY (2015)
Mast Cells, Mastocytosis, and Related Disorders
Theoharis C. Theoharides et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mastocytosis- a mutated KIT receptor induced myeloproliferative disorder
Anindya Chatterjee et al.
ONCOTARGET (2015)
Down-Regulation of MicroRNA-223 Promotes Degranulation via the PI3K/Akt Pathway by Targeting IGF-1R in Mast Cells
Quan Wang et al.
PLOS ONE (2015)
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal
P. Valent et al.
ANNALS OF ONCOLOGY (2014)
Epigenetics in the hematologic malignancies
Chun Yew Fong et al.
HAEMATOLOGICA (2014)
Cancer genomics identifies disrupted epigenetic genes
Laia Simo-Riudalbas et al.
HUMAN GENETICS (2014)
Proteolytic Histone Modification by Mast Cell Tryptase, a Serglycin Proteoglycan-dependent Secretory Granule Protease
Fabio R. Melo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
Paula de Melo Campos et al.
LEUKEMIA RESEARCH (2014)
Identification of functional cooperative mutations of SETD2 in human acute leukemia
Xiaofan Zhu et al.
NATURE GENETICS (2014)
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
Gandhi Damaj et al.
PLOS ONE (2014)
Loss of Function of TET2 Cooperates with Constitutively Active KIT in Murine and Human Models of Mastocytosis
Serena De Vita et al.
PLOS ONE (2014)
Epigenetics across the human lifespan
Riya R. Kanherkar et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2014)
Comprehensive mutational profiling in advanced systemic mastocytosis
Juliana Schwaab et al.
BLOOD (2013)
TETonic shift: biological roles of TET proteins in DNA demethylation and transcription
William A. Pastor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand
Viviane Ghanim et al.
BLOOD (2012)
Dnmt3a is essential for hematopoietic stem cell differentiation
Grant A. Challen et al.
NATURE GENETICS (2012)
Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
Fabiola Traina et al.
PLOS ONE (2012)
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells
Karin Ekstroem et al.
JOURNAL OF EXTRACELLULAR VESICLES (2012)
KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation
Youl-Nam Lee et al.
BLOOD (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Epigenetics and lifestyle
Jorge Alejandro Alegra-Torres et al.
EPIGENOMICS (2011)
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Ramiro Garzon et al.
BLOOD (2009)
Epigenetics: Connecting Environment and Genotype to Phenotype and Disease
S. P. Barros et al.
JOURNAL OF DENTAL RESEARCH (2009)
MicroRNA-221-222 Regulate the Cell Cycle in Mast Cells
Ramon J. Mayoral et al.
JOURNAL OF IMMUNOLOGY (2009)
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
A. Tefferi et al.
LEUKEMIA (2009)
Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias
Giuseppe Leone et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Distinct and shared transcriptomes are regulated by microphthalmia-associated transcription factor isoforms in mast cells
Amir H. Shahlaee et al.
JOURNAL OF IMMUNOLOGY (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders:: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients
Andres C. Garcia-Montero et al.
BLOOD (2006)
MicroRNA profiling of the murine hematopoietic system
S Monticelli et al.
GENOME BIOLOGY (2005)
Diagnosis and classification of mast cell proliferative disorders: Delineation from immunologic diseases and non-mast cell hernatopoietic neoplasms
P Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria
P Valent et al.
LEUKEMIA RESEARCH (2003)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
Share Paper
